For the third time in two months, Catherine DeAngelis, the editor-in-chief of the Journal of the American Medical Association [3] (JAMA), has been embarrassed by revelations that articles published in the journal have not included full disclosure by authors of their drug industry funding. The latest edition of JAMA includes a study [4] which links severe migraines to heart attacks in women. "All six of the study's authors have done consulting work or received research funding from makers of treatments for migraines or heart-related problems," reported Lindsay Tanner for Associated Press. "Authors should always err on the side of full disclosure," DeAngelis wrote in a note to readers [5]. The Center for Science in the Public Interest argues [6] that journals should institute a three-year ban for non-disclosure and the penalty should apply to all publications involved in the International Committee of Medical Journal Editors. Last week, DeAngelis told [7] (sub req'd) the Wall Street Journal she was against instituting a ban.